This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kindy, M. S. Articles by Rader, D. J. Search for Related Content PubMed PubMed Citation Articles by Kindy, M. S. Articles by Rader, D. J.

American Journal of Pathology, Vol 152, 1387-1395, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice

MS Kindy and DJ Rader
Department of Biochemistry, University of Kentucky School of Medicine, and the Veterans Affairs Medical Center, Lexington 40536-0084, USA. mskindy@pop.uky.edu

Apolipoproteins have been implicated in the formation of amyloid fibrils. Recent studies have demonstrated that apolipoprotein E (apoE), alone or in combination with apolipoprotein J (apoJ), and other lipoproteins appear to enhance deposition of amyloid fibrils both in systemic and cerebral amyloids, especially Alzheimer's disease (AD). ApoE enhanced the ability of the amyloid beta-protein (1-40) fragment (A beta) to form fibrils in vitro, with apoE4 promoting the greatest fibril formation. ApoE was found associated with both human and mouse amyloid A (AA) deposits. To define the role of apoE in vivo, we utilized mice lacking the apoE gene by gene targeting. We used the AA model in mice to characterize the function of the apoE protein in amyloid fibrillogenesis. ApoE-deficient mice exhibited a decrease in deposition of AA when compared with heterozygous mutant or wild-type animals. In addition, apoE-deficient mice that were injected with an adenovirus that expressed the human apoE3 gene had restored AA deposition and the apoE was associated with the AA fibrils. These results are agreement with the in vitro studies using the beta-peptide and suggest that apoE is not essential for amyloid fibrillogenesis but can promote the development of amyloid deposition.

This article has been cited by other articles:

				R. Kisilevsky, W. A. Szarek, J. B. Ancsin, E. Elimova, S. Marone, S. Bhat, and A. Berkin Inhibition of Amyloid A Amyloidogenesis in Vivo and in Tissue Culture by 4-Deoxy Analogues of Peracetylated 2-Acetamido-2-Deoxy-{alpha}- and {beta}-D-Glucose: Implications for the Treatment of Various Amyloidoses Am. J. Pathol., June 1, 2004; 164(6): 2127 - 2137. [Abstract] [Full Text] [PDF]

				J.-t. Guo, J. Yu, D. Grass, F. C. de Beer, and M. S. Kindy Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in a Mouse Model of Amyloidosis J. Neurosci., July 15, 2002; 22(14): 5900 - 5909. [Abstract] [Full Text] [PDF]

				M. S. Kindy, M. C. de Beer, J. Yu, and F. C. de Beer Expression of Mouse Acute-Phase (SAA1.1) and Constitutive (SAA4) Serum Amyloid A Isotypes : Influence on Lipoprotein Profiles Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1543 - 1550. [Abstract] [Full Text] [PDF]

				H. K. Edskes and R. B. Wickner A protein required for prion generation: [URE3] induction requires the Ras-regulated Mks1 protein PNAS, June 6, 2000; 97(12): 6625 - 6629. [Abstract] [Full Text] [PDF]